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Maintenance  of  a genome  requires  DNA  repair  integrated  with  chromatin  remodeling.  We have  ana-
lyzed  six  transcriptome  data  sets and  one  data  set  on  translational  regulation  of  known  DNA  repair  and
remodeling  genes  in  synchronized  human  cells.  These  data  are available  through  our  new  database:
www.dnarepairgenes.com. Genes  that  have  similar  transcription  proﬁles  in at least  two  of our  data  sets
generally  agree  well  with  known  protein  proﬁles.  In brief,  long  patch  base  excision  repair  (BER)  is  enriched
for S phase  genes,  whereas  short  patch  BER uses  genes  essentially  equally  expressed  in all  cell cycle  phases.
Furthermore,  most  genes  related  to  DNA  mismatch  repair,  Fanconi  anemia  and  homologous  recombina-
tion  have  their  highest  expression  in  the  S phase.  In  contrast,  genes  speciﬁc  for  direct  repair,  nucleotide
excision  repair,  as  well  as non-homologous  end  joining  do not  show  cell  cycle-related  expression.  Cell
cycle  regulated  chromatin  remodeling  genes  were  most  frequently  conﬁned  to G1/S  and  S.  These  include
e.g. genes  for  chromatin  assembly  factor  1  (CAF-1)  major  subunits  CHAF1A  and  CHAF1B;  the  putative
helicases  HELLS  and  ATAD2  that both  co-activate  E2F  transcription  factors  central  in  G1/S-transition  and
recruit DNA  repair  and  chromatin-modifying  proteins  and  DNA  double  strand  break  repair  proteins;
and  RAD54L  and  RAD54B  involved  in  double  strand  break repair.  TOP2A  was  consistently  most  highly
expressed  in  G2,  but  also  expressed  in late  S phase,  supporting  a role in  regulating  entry  into  mitosis.
Translational  regulation  complements  transcriptional  regulation  and  appears  to  be  a relatively  common
cell cycle  regulatory  mechanism  for DNA  repair  genes.  Our  results  identify  cell cycle  phases  in  which  dif-
ferent  pathways  have  highest  activity,  and  demonstrate  that  periodically  expressed  genes  in  a pathway
are frequently  co-expressed.  Furthermore,  the  data  suggest  that  S phase  expression  and over-expression
of  some  multifunctional  chromatin  remodeling  proteins  may  set up feedback  loops  driving  cancer  cell
proliferation.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND. IntroductionRepair of damage to DNA requires complex biological mech-
nisms that are tightly regulated and integrated. Damage that is
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oining; HR, homologous recombination; FA, Fanconi anemia; SS, serum starvation;
T,  double thymidine block; NZ, nocodazole; MS,  mitotic shake off.
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not corrected prior to replication may  be cytotoxic and mutagenic,
making DNA damage responses during the cell cycle of particu-
lar interest. Some proteins have DNA repair as their sole or main
function. However, a number of DNA repair proteins also have addi-
tional functions, e.g. in adaptive immunity [1], transcription [2] and
in replication [3]. Progression of cell cycle processes is normally
monitored by distinct checkpoints in G1/S, intra-S and G2/M. These
checkpoints control the progression through the various phases
of the cell cycle. Although the checkpoints are distinct, they all
respond to lesions in DNA and share several proteins [4]. Check-
point activation and recruitment of DNA damage response proteins
depend on the type of lesion [5]. Below we have brieﬂy outlined
characteristics of the major DNA repair mechanisms.
Base excision repair (BER) is a highly versatile DNA repair mech-
anism that corrects a very large number of small base lesions caused
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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y oxidation, deamination and alkylation. The pathway is initiated
y one among 11 known mammalian DNA glycosylases that rec-
gnize and remove the damaged base. BER is completed by a short
atch or a long patch repair route that in part use different pro-
eins in the downstream steps [6]. Some BER factors are known to
e regulated in a cell cycle speciﬁc manner. Speciﬁcally, expres-
ion of uracil-DNA glycosylase encoded by the UNG gene peaks in
ate G1 and S phase both at transcript and protein levels [7–10],
hereas thymine/uracil mismatch glycosylase TDG peaks through-
ut G1 phase and declines in the S phase [9]. However, upregulation
f nuclear UNG in G1 phase and strong downregulation in S phase
as reported by one group [11]. The reason for this inconsistency
s not known.
Mismatch repair (MMR)  corrects base-base mismatches and
nsertion/deletion loops generated during DNA replication and
ecombination. Since MMR  is an immediate post-replicative correc-
ion mechanism, a prediction would be that the proteins involved
re cell cycle regulated. Some key factors in MMR,  e.g. MSH2 and
LH1 proteins were indeed reported to be upregulated when qui-
scent cells were stimulated to proliferate, but ﬂuctuation through
ell cycle phases was less clear [12,13]. MMR  also requires several
eplication factors, such as DNA polymerases, EXO1, RFC and PCNA
14].
Nucleotide excision repair (NER) is the principal repair mech-
nism for DNA damage causing helix distortion, most commonly
yrimidine dimers from ultraviolet light, and requires more than 30
ene products, some unique and other shared with DNA replication
nd transcription [15].
Double strand breaks (DSBs) are highly toxic lesions that
ay cause various mutations, deletions and oncogenic translo-
ations. They may  be caused directly by ionizing radiation, or
ndirectly by endogenous or exogenous challenges that cause single
tranded breaks that, unless repaired, are converted to DSBs upon
eplication. Repair of DSBs in mammalian cells takes place by non-
omologous end joining (NHEJ) or related alternative mechanisms
n all cell cycle phases and in addition by homologous recombi-
ation (HR) repair during S phase and G2 phase, when a sister
hromatid is available [16,17].
Interstrand crosslinks (ICLs) may  be formed by environmental
utagens, as well as a number of chemotherapeutic drugs. ICLs
epresent a highly toxic type of lesion, the processing of which
equires input from several repair mechanisms, including NER, HR,
MR,  NHEJ, translesion polymerases and, importantly, a number of
anconi anemia (FA) proteins. Deﬁciency in FANC-proteins is asso-
iated with high sensitivity to agents that cause ICLs. Furthermore,
epair of ICLs may  use different mechanisms in different cell cycle
hases [18].
Methods for cell cycle synchronization include temporary
rowth arrest in the G1/G0-phase at high cell density or serum
tarvation, as well as block of cell cycle progression at the G1/S
hase transition or in the G2 phase. Alternatively, enrichment of
ells in certain cell cycle phases without chemical treatment may
e obtained by mitotic shake off, elutriation centrifugation or by
ther means. These methods all have advantages and drawbacks,
ncluding limited synchrony, cell line-speciﬁc differences, intra-
ulture heterogeneity, toxicity of chemicals changing expression,
mall yield of cells and requirement for specialized instrumenta-
ion. It is advantageous if cultures can be followed through two or
ore rounds of the cell cycle and the method should ideally fulﬁll
 set of deﬁned criteria [19]. For example, the growth as well as the
ntegrity of the cells should not be affected by the synchronization
rocess [19]. A good synchronization also requires limited increase
n cell number between each successive division [19]. To investigate
enome-wide expression of cell cycle-associated genes, microarray
nalyses of synchronized cells have been carried out using differ-
nt eukaryotic cell lines [20–25]. Results from cell cycle studiesir 30 (2015) 53–67
show that functionally distinct classes of genes are expressed at
the highest level when they are needed [25–27]. Whereas the reg-
ulation of protein complexes frequently has evolved differently in
different species, regulated subunits of proteins or complexes are
usually expressed just before their time of action. Furthermore,
changes in transcriptional regulation have frequently co-evolved
with post-translational control [26].
Here we have used available data sets to examine transcrip-
tion proﬁles and translational regulation of all known human
DNA repair and chromatin remodeling genes during the cell cycle.
These data sets use different synchronization procedures and cell
lines, which reduce the risk of method-associated errors. Periodic
expression of transcripts does not prove that protein levels ﬂuc-
tuate correspondingly. However, from a number of earlier studies,
expression at transcript and protein levels of several DNA repair and
remodeling genes are known [25,27–30]. Reassuringly, our results
are in good agreement with these results, as discussed below.
Furthermore, DNA repair and remodeling often use multi-subunit
proteins or complexes to carry out the task. Based on available
information [26], it may  be fair to hypothesize that if at least one of
the required and critical subunits in a protein or protein complex is
clearly cell cycle regulated, the function of the protein or complex
is likely to be cell cycle regulated. Our studies identify a number
of DNA repair and chromatin remodeling genes that are cell cycle
regulated, most commonly peaking in the G1/S or S phase. Further-
more, the information identiﬁes gene sets that likely contribute to
overall regulation of pathways and subpathways.
2. Materials and methods
2.1. DNA repair and chromatin remodeling genes
A list of 177 DNA-repair genes published previously [31,32]
was used and supplemented with additional bona ﬁde DNA repair
genes identiﬁed by PubMed searches, to give a sum of 345 DNA
repair genes. The list of established and putative genes for chro-
matin remodeling proteins contains 99 genes. They were compiled
from a comprehensive literature search carried out by members of
the FANTOM5 consortium (EpiGenes 1.3; F. Drabløs, Y. Medvedeva,
A. Lennartsson, unpublished data) and supplemented with novel
information from data searches. The new database named “Cell
Cycle Regulation of DNA Repair and Chromatin Remodeling Genes”
is found here: www.dnarepairgenes.com. We  have consistently
used the HUGO Gene Nomenclature Committee (HGNC) approved
gene names in the new database, as well as in the paper. The alter-
native names can be found in OMIM.
2.2. Data sets in the novel database
Seven time series gene expression data sets from ﬁve differ-
ent studies were downloaded and analyzed. These include primary
foreskin ﬁbroblasts synchronized in G0-phase by serum starvation
[20]; HaCaT cells, a near diploid keratinocyte cell line, synchronized
at G1/S-transition by double thymidine block [22]; human cervical
carcinoma HeLa cells synchronized in M by nocodazole [22] or in
G1/S transition by double thymidine block (this paper, see Supple-
mentary Materials); HeLa cells using double thymidine block and
nocodazole [33]; or HeLa cells synchronized by double thymidine
block, nocodazole and mitotic shake-off [25]. These studies, except
[33], were carried out using gene expression microarrays to analyze
multiple time points during one or several cell cycles. The single
data set available on translational regulation in HeLa cells by ribo-
some proﬁling using RNA sequencing, as well as the accompanying
transcriptome, were based on three time points only (G1, S and G2)
[33]. These therefore do not discriminate between genes expressed
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n early/middle G1, and genes expressed at the G1/S transition. Note
hat as this study speciﬁcally measured changes in translational
ates relative to transcriptional levels, some genes were identiﬁed
s translationally regulated in all three phases.
.3. Analysis of transcript proﬁles
Cell cycle regulated genes were identiﬁed using partial least
quare (PLS) regression on to a sine and cosine function with
eriods equal to the speciﬁc cells’ cell cycle duration as estimated
y ﬂow cytometry analyses of DNA content. PLS regression is a
imension reduction technique that tries to ﬁnd the main prin-
ipal directions in the data that explain the main variation in the
esponse. In this case, the data are the gene expression proﬁles at
he different cell cycle time points and the response are the val-
es of the sine and cosine curves at the corresponding time points.
he main reason for using regression on to sine and cosine func-
ions is that these functions are ideal for modeling the expected
yclic expression proﬁles of cell cycle regulated genes. Moreover,
s the sine and cosine functions are orthogonal functions, the ﬁrst
nd second principal components of the PLS regression will form
n abstract phase diagram where the phase angle and distance
rom the origin of each gene can be directly interpreted as the
ene’s peak point in the cell cycle and the peak’s relative height,
espectively. Based on this phase angle, each gene was assigned a
ell cycle phase by comparing its phase angle to those of a small
et of genes with previously well-described cell cycle proﬁles, as
escribed [22].
Transcription data from Stumpf et al. [33] were analyzed by
sing TopHat [34] and Cufﬂinks [35] followed by EBSeq in R [36] to
ompare the three individual time points, one from each cell cycle
hase. Speciﬁcally, TopHat was used to map  the sequence reads to
he human genome. The expression of each gene was determined
sing Cufﬂinks that counts the number of reads that match to a
iven RefSeq transcript. EBSeq was used to determine differential
xpressed transcripts between the cell cycle phases. EBSeq uses the
utput from Cufﬂinks and estimates expression differences for all
ene isoforms.
. Results and discussion
.1. Organization of the new database “cell cycle regulation of
NA repair and chromatin remodeling genes”
The screen shot shows key features of the novel database on
ell cycle regulated DNA repair genes and chromatin remodeling
enes (Fig. 1). The horizontal menu line displayed in the ﬁgure
an be used to maneuver to any part of the database. The ARTICLE
ill contain the published form of the present paper. The GENE
IST lists all identiﬁed DNA repair genes and chromatin remodel-
ng genes separately, both cell cycle regulated and not cell cycle
egulated ones. By clicking on the name of individual genes, infor-
ation in OMIM is available. The banner CELL CYCLE lists the
ell cycle regulated DNA repair and chromatin remodeling genes,
s separate lists, with reference to source of the data sets. Each
ene has been assigned to the cell cycle phase in which it has the
ighest expression in each of the studies included. A transcrip-
ome expression proﬁle for each gene, based on data from our
aboratory [22], foreskin ﬁbroblasts [20], and this paper (listed as
jelle et al., 2014 in the database; see also Supplementary Materi-ls and Supplementary Fig. 1), can be reached by clicking on the
ene name. Expression data from the other studies [25,33] can
e reached by clicking METHODS in the menu line and then the
elevant study.ir 30 (2015) 53–67 55
3.2. Results of the analyses – overview
To reduce false positives, we limited detailed transcriptome
analyses [20,22,25,33] to genes that were cell cycle regulated in
at least two  data sets. For analyses of translational regulation, the
single data set available was used [33]. In sum, when analyzing
the transcriptome data sets for which expression proﬁles is dis-
played in the novel database, we  observe an enrichment of DNA
repair genes among cell cycle regulated genes (17% compared to
8% for all genes, p = 5.7e−9), whereas the number of cell cycle reg-
ulated chromatin remodeling genes is not higher than expected
(11% compared to 8% for all genes, p = 0.27). More detailed informa-
tion, including expression proﬁles, is found in the novel database:
www.dnarepairgenes.com. This page gives information for differ-
ent cell lines, cell cycle phase of highest expression (with links to
expression proﬁles), chromosomal localization of the genes and
known and presumed gene functions (links to OMIM).
It should be understood that although many genes may be
upregulated several-fold in distinct cell cycle phases, a low level
of expression is usually observed in other cell cycle phases. Normal
primary ﬁbroblasts have the highest number of cell cycle regulated
genes (80 genes) suggesting that cell cycle regulation of several
genes involved in DNA repair may  be deranged in transformed cells.
This could not be explained by reduced synchrony in HaCaT and
HeLa cells (Supplementary Figure 1). In total, we  identiﬁed 124
DNA repair genes to be cell cycle regulated in at least one data
set, whereas 58 were cell cycle regulated in two or more data sets.
Genes with conserved expression proﬁles across experiments are
most frequently expressed in late G1 phase and S phase, although
some have distinct expression in other cell cycle phases, e.g. TOP2A
and ASF1A which are G2 phase regulated.
Although expression proﬁles differ signiﬁcantly between cell
lines, there is a reasonable overlap between the studies using tran-
scription proﬁling as tool. Furthermore, the relationship between
expression at the transcription level and protein level is known for
some DNA repair and remodeling genes. It is reassuring to notice
that transcript levels generally agree very well with protein data
(when known). Some examples include G1/S genes UNG [10], PCNA
[37], POLD and POLA [38], BLM [39], BRCA1 [40], FEN1 [41], HELLS
[42], CHAF1A and CHAF1B [43], but also the G2  expressed gene
TOP2A [44,45]. In some cases the expression is upregulated both
transcriptionally and translationally in the same cell cycle phase,
e.g. MSH6, ATAD2 and POLA1, which are upregulated in G1/S or
S phase. There are also several examples of genes that are either
transcriptionally or translationally regulated. More detailed analy-
ses are found below.
3.3. Translational regulation in the cell cycle
In total, 30 DNA repair genes and 11 chromatin remodel-
ing genes were found to be translationally regulated in the cell
cycle. They were mostly upregulated, although three were down-
regulated, either in the G1 phase (BTG2 and Tp73) or S phase
(PAPD7). Thus, translational regulation is relatively common and
predominantly acts as a mechanism for upregulation of genes in
a cell cycle phase. Among the DNA repair genes, 13 were only
translationally regulated (e.g. KAT5, SMC3, ERCC4 and GTF2H2).
KAT5 (a histone Lys acetyltransferase, initially called TIP60), is
translationally upregulated in G1 phase and contributes to DSBR.
KAT5 acetylates ATM via chromatin binding and activates the ATM-
pathway [46]. SMC3 (structural maintenance of chromosomes 3)
is translationally upregulated in G1 and S phase. It is part of the
cohesion complex that keeps sister chromatids together and it is
important for DSBR by homologous recombination [47]. ERCC4
(also called XPF) is translationally upregulated in all three phases
examined (G1, S, and M)  and, strictly speaking, not cell cycle
56 R. Mjelle et al. / DNA Repair 30 (2015) 53–67
Fig. 1. Overview of the database’s key features. (A) The database’s main page (HOME) has a menu that provides links to background information about the database (ARTICLE,
METHODS, RESEARCH GROUP) and links to the database’s main sections, which are the lists of chromatin remodeling and DNA repair genes (GENE LISTS) and their cell cycle
expression proﬁles (CELL CYCLE). (B) The “GENE LISTS” pages provide links to information about each gene’s function and genomic context. Chromatin remodeling and DNA
repair  genes have separate pages; shown here is an excerpt of the DNA repair genes. Note that some multifunctional genes, such as HELLS or TOP2A, are present on both. (C)
The  “CELL CYCLE” pages show chromatin remodeling and DNA repair genes with signiﬁcant cell cycle dependent regulation in at least one of the seven datasets examined.
Abbreviated cell cycle phases (G1/S, S, G2, G2/M, and M/G1) show the phase in which a gene has its peak expression. The abbreviations NR and NTR indicate datasets in which
the  gene was  not detected to be transcriptionally or translationally regulated, respectively. Chromatin remodeling and DNA repair genes have separate pages; shown here
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hase  distribution for the ﬁrst four experiments listed in the table. (D) The express
egulated. ERCC4 is best known for its function as a structure-
peciﬁc endonuclease in complex with ERCC1 in NER, but is also
nvolved in ICL repair and DSBR [48]. GTF2H2, a subunit of TFIIH,
s translationally upregulated in G1 phase and is required both for
ER and transcription.
.4. Genes encoding base excision repair (BER) and single strand
reak repair (SSBR) proteins
The damage recognizing proteins in BER are DNA glycosylases
hat remove damaged bases that do not cause major distortion to
he DNA helix structure. SSBR is generally using proteins involved
n the downstream steps of BER, although this may  be a sim-
listic view. The 11 human DNA glycosylases identiﬁed recognize
oth spontaneous and induced lesions. Four of the genes encod-
ng DNA glycosylases were found to be cell cycle regulated; these
re UNG, TDG, NTHL1 and NEIL3. UNG and NTHL1 are expressed at
1/S, NEIL3 in S/G2 and TDG in G1. In addition, UNG is transla-
ionally upregulated in G1. We  found no evidence for cell cycle
egulation of MPG, SMUG1,  MBD4,  NEIL1, OGG1 and MUTYH (Fig. 2).
owever, evidence for S phase expression was previously reported
or NEIL1 when using prolonged serum starvation to synchronize
broblasts [49]. The opposite expression pattern of UNG and TDG
as been reported previously, both at the mRNA and protein levels
9] and our results are consistent with previous ﬁndings [9,50,51].
he G1/S expression of UNG is consistent with its deﬁned role
n immediate post-replicative removal of misincorporated dUMP
10,52], as well as its probable role in pre-replicative correction of
:G mismatches [53]. Nuclear UNG2 (encoded by UNG) and NEIL1
and NEIL3), unlike other DNA glycosylases, are highly active onene links to a ﬁgure (D) that shows the gene’s expression proﬁle and the cell cycle
oﬁles of FEN1.
single-strand and double-strand DNA and are located in replica-
tion foci during S phase [54]. Possibly, UNG2 and NEIL1 may  remove
damaged bases in single-stranded DNA at the replication fork, fol-
lowed by fork regression and BER by the usual mechanism for
double-stranded DNA, as suggested [53,54]. NEIL3 was recently
reported to be induced in late S phase in cells synchronized by den-
sity inhibition, but the data reveal that NEIL3 expression continues
into G2 [55], thus these data are consistent with our results. Sev-
eral genes involved in downstream steps of short-patch are not cell
cycle regulated, including POLB, encoding DNA polymerase , POLL,
encoding DNA polymerase , APEX1,  encoding AP-endonuclease 1
and PNKP, encoding polynucleotide kinase phosphatase. Interest-
ingly, PARP1 and PARP2 are S phase regulated in normal ﬁbroblasts,
consistent with a role of PARP in SSB and at least some forms of BER,
but apparently not all [56]. The genes for proteins in the down-
stream steps of long-patch BER (LIG1, PCNA, FEN1, POLD1,  POLD3,
POLE and POLE2), are all consistently S phase or G1/S regulated.
All proteins from these genes are also replication proteins. LIG1 is
involved in short patch repair as well, whereas LIG3 is probably
involved in nuclear short patch BER and essential for mitochon-
drial BER (reviewed in [6]). These results support a model where
long patch BER is mainly acting in proliferating cells and that repair
by long patch BER is carried out by genes induced in late G1 and
early S phase, in agreement with previous results on in vitro BER
in cell extracts [57]. The S phase expressed POLA1 encodes DNA
polymerase /primase and has relatively low ﬁdelity due to lack
of 3′ → 5′ proofreading activity. It is not thought to be involved in
BER but appears to be involved in repair of SSBs during replication
through binding of XRCC1, presumably near the replication fork
[58].
R. Mjelle et al. / DNA Repair 30 (2015) 53–67 57
Fig. 2. Cell cycle regulated genes in the BER pathway. The genes are marked with colors according to which cell cycle phase they have highest expression, as indicated in the
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.5. Genes encoding proteins involved in direct repair of base
esions
Generally, genes encoding proteins involved in direct repair of
ase alkylations are not cell cycle regulated (Fig. 3). This applies
o MGMT  required for repair of the highly mutagenic DNA lesion
6-methylguanine, as well as human AlkB homologues ALKBH1,
LKBH2 and ALKBH3. ALKBH2 was cell cycle regulated to G1 phase
n one HeLa cell strain and S in another, but not cell cycle regu-
ated in ﬁbroblasts and HaCaT cells. Since alkylation lesions may
ccur at all cell cycle stages from normal metabolites (e.g. S-
denosylmethionine) as well as external challenges, the general
bsence of cell cycle regulation of these genes would be an expected
utcome.
.6. Genes encoding nucleotide excision repair (NER) proteins
NER is required for excision repair of bulky DNA adducts, e.g.
rom ultraviolet light. Genes for repair proteins involved in the
nitial steps in NER by both global genome repair (GGR) and
ranscription coupled repair (TCR) appear to be expressed indepen-
ently of cell cycle phases, although most genes in the downstream
teps are upregulated in S phase (Fig. 4). Thus, CSA (ERCC8) and CSB
ERCC6) required for TCR, are not detected as cell cycle regulated
t the transcript level, neither are the XPC-RAD23B-complex in
GR or any of the other XP-genes, including XPA, XPB (ERCC3), XPD
ERCC2), XPE (DDB1), XPF (ERCC4) or XPG (ERCC5). However, ERCC4studies, or translationally regulated [33] are colored. Note that gene products have
ray ﬁll in ovals indicate that the genes are not found to be cell cycle regulated (not
is translationally upregulated in G1, S and M.  Furthermore, the ﬁnal
steps of the pathway, which are in part shared with DNA replication
and other excision repair pathways, use cell cycle regulated genes
that are most frequently upregulated during G1/S phase, includ-
ing RPA1, PCNA, RFC4 and RFC5 (subunits of RFC), LIG1, POLD1 and
POLD3 (subunits of POL) and POLE and POLE2 (encoding POL).
In addition, POLK (encoding POL) is translationally upregulated in
the S phase. For gap ﬁlling, ubiquitinated PCNA recruits POL to the
site of DNA damage, where it is found in complex with POL. These
polymerases are responsible for synthesis of approximately half of
the repair gap and POL the rest [59]. Furthermore, UV-induced
nuclear import of XPA primarily takes place in the S phase and
appears to initiate NER in a p53-dependent manner [60]. The NER
endonuclease XPG and the closely related yeast homolog Rad2 have
a PCNA-binding domain in the C-terminal region. The Rad2-PCNA
interaction was recently found to mediate arrest of cell cycle pro-
gression, suggesting a role of XPG/Rad2 other than the established
endonuclease function [61].
3.7. Genes encoding mismatch repair (MMR) proteins
MMR  proteins are primarily required for correction of mis-
matches from replication errors. Some studies have reported cell
cycle dependent expression of MMR  genes while others have noted
just moderate ﬂuctuations throughout the cell cycle [12,62,63]. We
observe that the genes encoding major components in mismatch
recognition are transcriptionally up-regulated in S or G1/S phase
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n normal ﬁbroblasts, including MLH1, MSH2 and MSH6. MSH6 is
pregulated in S phase in all cell lines, whereas the other com-
onents are less consistently upregulated. In addition, MSH2 and
SH6 are translationally upregulated in G1/S or S phase (Fig. 5).
SH3 is apparently not cell cycle regulated. Generally, MSH het-
rodimers recognize mismatches, whereas MLH  heterodimers are
trand-speciﬁc endonucleases. The MSH2-MSH6 complex (MutS)
ecognizes single nucleotide mismatches, whereas the MSH2-
SH3 complex (MutS)  recognizes insertion/deletion loops. MutL
omologues PMS1 and PMS2 form heterodimers with MLH1.
mong these, PMS2 is translationally upregulated in G1. MSH4
nd MSH5, the expression of which is normally largely limited to
vary and testis, are not cell cycle regulated in the cell lines exam-
ned. The MSH4-MSH5 complex recognizes Holliday junctions and
orms a sliding clamp during meiosis, but has no apparent role
n replication-associated MMR,  thus there is no speciﬁc require-
ent for these components during S phase [64]. The gene encoding
he 5′ → 3′ excision nuclease EXO1, required for damaged strand
Fig. 4. Cell cycle regulated genes in the NER pathway; see Fig. 2 f are not cell cycle regulated.
excision in MMR  is upregulated in G1/S or S phase. EXO1 has mul-
tiple functions in DNA maintenance, including MMR,  replication,
recombination and telomere maintenance, processes that are all
associated with S phase in mammalian cells. As expected, other
replication-related genes active in re-synthesis and ligation are up-
regulated during S phase, including RFC3, RFC4, RFC5, PCNA, RPA1,
POLD1, POLD3 and LIG1. Thus, expression patterns of genes for MMR
proteins collectively comply with their roles in MMR,  HRR and
replication.
3.8. Genes encoding Fanconi anemia (FA) pathway proteins
FA proteins have a major role in repair of inter-strand cross links
(ICLs). FA is associated with increased cancer risk and cellular sen-
sitivity to inter-strand crosslinking agents and ionizing radiation
[65]. The majority of FA genes are upregulated in G1/S at the tran-
script level in at least two  data sets (11 genes) or translationally
upregulated in the S phase (3 genes). Repair processes requiring FA
or an explanation of the color codes. Genes initiating NER.
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roteins are not limited to ICLs, although they apparently have a
ritical role there. The FA pathway is damage-inducible by repli-
ation fork-stalling lesions that activate ATR kinase, which in turn
ctivates some proteins in the FA core complex. The FA pathway is
omplex and involves 13 FANC genes (FANC A, B, C, D1, D2, E, F, G, I, J,
, M and N) and other genes as well, including the S phase expressed
enes BLM (helicase), USP1 (deubiquitinase), BRCA1,  RPA1, RAD1 and
AD51. Genes for most components in the FA core complex (FANC A,
, E and L, but not C and F) are up-regulated during S phase (Fig. 6).
lthough FANCM is not S phase expressed at transcript level, it is
ranslationally upregulated in the S phase. Upon activation, the FA
ore complex ubiquitinates the I–D2 complex consisting of FANCI
nd FANCD2, which are apparently transcriptionally up-regulated
uring late S- and G2-phase. The I-D2 complex is required to pro-
ote repair by homologous recombination, which in mammalian
ells takes place in the S- and G2 phase. The I-D2 complex in turn
ctivates the downstream components BRCA2 (FANCD1), RAD51
nd RAD51C, among which the critical damaged DNA-binding pro-
ein RAD51 is upregulated during G1/S- and S phase. FAN1 (Fanconi
nemia associated nuclease 1) is required for ICL repair, but is not
ell cycle regulated [66]. However, the FA complex may  also be acti-
ating the MMR  pathway through the interaction with FAN1, MLH1; see Fig. 2 for an explanation of the color codes.
and PMS2 [66], among which MLH1 is upregulated in S phase, and
PMS2 translationally upregulated in G1. In conclusion most of the
FA proteins and some associated proteins are S phase regulated, in
agreement with the view that repair of ICLs is most efﬁcient in the
S phase.
3.9. Genes for homologous recombination repair (HRR)
In mammalian cells, HRR is restricted to the S phase and G2
phase, using the sister chromatid rather than the homologous chro-
mosome for strand exchange [17]. Consistent with this, many of the
genes involved in HRR are most highly expressed in S phase. Homol-
ogous recombination is initiated by the MRN  complex consisting of
MRE11A, RAD50 and NBN (NBS1). Among these, MRE11A is found
to be induced in late S- and G2 phase whereas NBN is induced in G1
and G1/S (Fig. 7). Furthermore, PARP1 apparently has a role in facil-
itating HRR at DSBs resulting from collapsed replication forks by
binding to DNA ends and inhibiting competitive binding of Ku70/80
and thereby preventing less accurate repair by NHEJ [67,68]. We
do not ﬁnd PARP1 convincingly cell cycle regulated, although
it is upregulated in the S phase when ﬁbroblasts are released
from serum starvation. One function of PARP1 in HRR may be
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ecruitment of the heterodimer of BRCA1 and BARD1, each of which
 phase-regulated. This recruitment is parylation-dependent [69].
n addition, SMC3 is translationally upregulated in G1/S, but not
ranscriptionally regulated. SMC3 is part of the cohesion complex
hat keeps sister chromatids together and is important for DSBR bysee Fig. 2 for an explanation of the color codes.
HR [47]. Homology search and DNA-strand invasion is performed
by RAD51, which is upregulated during G1/S and S phase across
three cell lines. The gene encoding RAD54, a RAD51-interacting
protein required for stabilizing RAD51, is also up-regulated dur-
ing S phase. RAD51-mediated strand exchange was found to be
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timulated by the PSMC3IP-MND1 complex. PSMC3IP (also called
OP-2) is expressed in G1/S and was recently reported to have a
egulatory role both in DSBR and recombination [70]. A recently
escribed RAD51 interaction partner, FIGNL1 [71], interacts specif-
cally with RAD51 and is upregulated in the S phase, similar to see Fig. 2 for an explanation of the color codes.
RAD51. Of the genes in the post-synapsis step, BLM [72] is found
to be up-regulated in S phase in all four cell lines and BRCA2 is
possibly upregulated during G2 phase (in ﬁbroblasts only). In con-
clusion, many of the genes required for HRR are upregulated in S
phase, consistent with the activity of this process in the S phase.
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.10. Genes encoding proteins for non-homologous end joining
NHEJ) – a regulatory role for PTTG/securin
Generally, genes centrally involved in NHEJ were found not
o be cell cycle regulated (Fig. 8). However, PTTG1,  encoding the
02 amino acids protein PTTG1 (also called securin), consistently
ad the highest transcript level at the M/G1-transition in all data
ets and then declines rapidly during the G1 phase. PTTG1 is
 multifunctional and rather intriguing protein. It binds directly
o Ku70 (also called XRCC6) and functions as a negative regula-
or of NHEJ [73,74]. Thus, PTTG1 may  inhibit illegitimate NHEJ
ntil completion of replication. It was reported that PTTG1 is
biquitinated at metaphase-anaphase transition by the E3 ligase
naphase-promoting complex (APC). It is then normally rapidly
egraded in proteasomes (reviewed in [75]), thus alleviating the
HEJ-inhibition and reestablishing the capacity for NHEJ during
1 phase. Importantly, PTTG1 also controls sister chromatid sepa-
ation during mitosis by binding to and inhibiting separase, which
hen active cleaves cohesin that holds sister chromatids together
76]. Normal levels of PTTG1 may  prevent premature sister chro-
atid separation, thus facilitating DNA repair by HRR during the
 phase and G2. However, overexpression of PTTG1 correlates
trongly with aneuploidy in breast cancer [77], possibly due to an
nability of sister chromatids to separate. Overexpression of PTTG1
s associated with a wide range of malignancies, e.g. hematopoi-
tic malignancies [78], colon cancer [79] and breast cancer [80].
hus, while PTTG1 normally regulates several processes important
o genomic stability, overexpression appears to promote genomic
nstability, stimulate proliferation and contribute to carcinogene-
is. PTTG1 also functions as a transcriptional regulator of several
enes involved in tumorigenesis [81]. We  conclude that normally
he transcript level of PTTG1 is upregulated at the M/G1-transition,
ut subsequently ubiquitinylated and degraded in proteasomes; see Fig. 2 for an explanation of the color codes.
at metaphase-anaphase transition, allowing chromatid separation.
Overexpression of PTTG1 apparently results in inability of sister
chromatids to separate with increased risk of aneuploidy in cancer
cells [82,83].
3.11. Chromatin assembly and remodeling in DNA repair
Chromatin remodeling complexes temporarily disrupt and
remodel DNA–nucleosome interactions, thus facilitating different
DNA transactions, including DNA replication, transcription and
repair [84,85]. We  examined 99 genes thought to be involved in
chromatin remodeling, many of which are already known to have
a function in DNA repair. Among these, 39 were found to be cell
cycle regulated in at least one transcriptome data set and 11 in
at least two data sets. While three remodeling genes were reg-
ulated both at the transcriptional and translational level, several
were only translationally regulated (CHD1, ACTL6A, ZRANB3, TP73,
SMARCA1, SMARCA5 and SMARCAD1). The cell cycle regulated
chromatin remodeling genes were largely G1/S-expressed genes,
except TOP2A, which displayed highest expression in G2 phase.
The CAF-1 (chromatin assembly factor 1) complex consists of
CHAF1A, CHAF1B and p50 and is generally required to assemble
nucleosomes after DNA synthesis. We ﬁnd that CHAF1A and CHAF1B
are consistently most highly expressed in G1/S. CAF-1 has a role in
MMR,  which itself has the major normal function in the S phase. In
MMR  the long repair patch is generated by the S phase-regulated
5′–3′ nuclease EXO1 [14]. After DNA re-synthesis in MMR,  the
CAF-1 complex is required to re-assemble nucleosomes, protecting
DNA from excessive degradation [86,87]. CAF-1 is also required to
restore chromatin after NER [88] and HRR [7], and is thus heavily
involved in DNA repair processes.
Genes for the putative ATPases/helicases ATAD2 (also called
ANCCA) and HELLS (also called LSH, PASG and SMARCA6) are also
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Fig. 9. Model for functions of HELLS – a multifunctional putative helicase and proliferation driver. (A) HELLS, has functions in development (epigenetics), as E2F co-activator
in  transcription to stimulate cell growth, as well as in repair of DSBs through increasing phosphorylation of H2AX to generate H2AX. (B) Overexpressed HELLS, ATAD2 and
E2Fs  may  set up functional loops that make them drivers of tumor cell proliferation. They are all S phase expressed and frequently overexpressed in tumors. HELLS and ATAD2
are  known to interact physically with E2Fs and function as co-activators of E2F-mediated transcription for a number of genes (but not necessarily all genes that use E2F as
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[ranscription factor). HELLS has been shown to mediate epigenetic silencing of P16
ctive  E2F1. In sum, HELLS, ATAD2 and E2Fs mediate expression of several genes th
onsistently most highly expressed in G1/S. In addition, ATAD2
s translationally upregulated in the S phase. HELLS has a docu-
ented function in DSBR [89], and ATAD2 is likely to be involved
n DNA repair. HELLS and ATAD2 are overexpressed in several can-
er types and are considered as proliferation drivers. HELLS and
TAD2 are signiﬁcantly coexpressed, with a Pearson correlation
oefﬁcient of 0.63 when analyzed using the database COEXPRESdb
90]. Through various interactions and diverse functions they have
he potential to set up feedback loops that enhance prolifera-
ion (Fig. 9). However, whereas HELLS is overexpressed and may
ontribute to tumor progression in prostate cancer [91], ATAD2
s apparently not signiﬁcantly expressed in prostate cancer, but
verexpressed in several other common cancers [92], similar to
ELLS. ATAD2 and HELLS are rather intriguing proteins that appear
o have several different roles in DNA transactions. They both
unction as co-activators for E2F transcription factors that stim-
late G1 to S phase transitions, as outlined below. ATAD2 is an
AA-protein type ATPase (ATPase Associated with diverse cellular
ctivities) that is thought to be involved in chromatin remodel-
ng and regulation of transcription [93]. Recruitment of ATAD2 to
hromatin requires its bromodomain that binds to histone H3K14ac
94] and histone H4K5ac [95]. Importantly, H3K14ac was recentlypression, thereby causing activation of CDK4, phosphorylation of RB and release of
ulate G1/S-transition and cell proliferation.
shown to facilitate nucleotide excision repair in yeast through
stabilizing binding of a chromatin remodeling complex [96]. As
mentioned, ATAD2 is overexpressed in a number of human can-
cers, but although ATAD2 is induced by estrogen and acts as a
co-regulator for estrogen and androgen receptors, overexpression
is not limited to hormone-dependent tumors [92,95,97–100]. Fur-
thermore, ATAD2 overexpression appears to act as a driver of
proliferation in cancer cells and is associated with poor progno-
sis [98,99]. Several observed functions of ATAD2 may  be related
to its direct interaction and function as co-activator for transcrip-
tion factors that are involved in G1/S-transitions and proliferation,
including E2F1, cyclin D1, MYC, B-MYB, histone methyltransferase
EZH2 and others [94,98–101]. It is reasonable to assume that the
G1/S-regulation of ATAD2 itself contributes to the speciﬁc S phase
functions of the gene products mentioned.
The G1/S regulated HELLS gene encodes an SNF2-related
ATPase/helicase and was identiﬁed as a putative helicase with
highest expression in T-cells in fetal mouse thymus [102], but
is generally expressed in proliferating cells. Transcription factor
FOXM1, reported to be G1/S regulated [103], is a central regula-
tor of HELLS expression [104]. However, our laboratory (data not
shown), as well as others, observed highest expression of FOXM1 in
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2/M/G1 [20,22,25], consistent with an additional important func-
ion of FOXM1 in regulation of several G2-speciﬁc genes as well
105,106]. HELLS promotes phosphorylation of H2AX to H2AX and
ontributes to efﬁcient repair of double-strand breaks in mouse
ells [89]. HELLS contributes to de novo methylation of DNA by
nteraction with DNA methyltransferases and is involved in regu-
ation of transcription [107–109]. It also has a role in methylation of
istone H3K4 [110]. Furthermore, HELLS silences expression of the
DK4-inhibitor p16INK4 by recruiting HDAC1 and possibly HDAC2
o the p16INK4 gene promoter, thereby increasing cell prolifera-
ion and delaying senescence [111]. The apparent role of HELLS
n progression of prostate cancer may  in part be explained by its
unction as a co-activator for transcription factor E2F3 [91]. In con-
rast, HELLS deﬁciency causes erythroleukemia in mice [108], and
eletions are associated with acute myeloblastic- and acute myel-
genic leukemia in humans [112]. In sum, the S phase regulated
ELLS contributes to DSBR by promoting phosphorylation of H2AX
o H2AX and has complex epigenetic functions at the DNA and
istone level. In addition, it acts as co-activator for transcription
actor E2F3 that increases expression of several growth promoting
enes. Depending on cell type it may  both prevent and promote
arcinogenesis.
Genes for RAD54B and RAD54L are also most highly expressed in
1/S or S phase. RAD54L (usually called RAD54) is a much-studied
ember of the SNF2 family of helicases, but may  not be a func-
ional helicase [113]. RAD54L interacts with RAD51, also a G1/S
NA repair and remodeling protein, to carry out the key reactions
f homology search and DNA strand invasion [113]. In this process
AD51-ssDNA stimulates RAD54L-dependent chromatin remodel-
ng in a homology-dependent manner [114]. RAD54B is another
ember of the SNF2 superfamily of helicases and is involved in DNA
epair by homologous recombination. In the nucleoplasm, RAD54B
o-localizes with RAD51 and BRCA1, both of which are also most
ighly expressed in G1/S. RAD54B is not an essential DNA repair
rotein, but it is synthetically lethal with loss of LIG4, required for
HEJ [115]. The mechanistic function of RAD54B in recombination
s not clear.
Topoisomerase II encoded by TOP2A consistently has highest
xpression in the G2 phase. This is in accordance with earlier
tudies on TOP2A protein levels demonstrating highest levels dur-
ng G2/M, although it is also expressed during the S phase [44].
nterestingly, subunits in the SWI/SNF complex, a much-studied
emodeling complex, is required for binding of TOP2A to 12,000
enomic binding sites, indicating that TOP2A depends on the
WI/SNF complex to prevent entanglement of DNA at mitosis [116].
 major regulator of the TOP2A promoter is the transcription fac-
or FOXM1, which itself peaks in S- and G2 phases of the cell
ycle and binds to the TOP2A promoter and other S/G2-regulated
enes [117].
.12. DNA polymerases
We  analyzed 16 DNA polymerase genes (including subunits) in
he list of DNA repair genes. Seven of these are cell cycle regulated.
NA pol1, pol1, pol3, pol and pol2 are all expressed during
1/S- or S phase. DNA pol ,  and  are members of the fam-
ly B polymerases, and the S phase dependent expression conﬁrms
heir role in DNA replication. Pol and pol	 are both most highly
xpressed in G2 phase. Pol is known to function in translesion
ynthesis in the FA pathway; it synthesizes DNA with low ﬁdelity
nd is proposed to have a role in somatic hypermutation (SHM) of
mmunoglobulin genes [118]. DNA pol is found to be independent
f cell cycle phase, as previously reported [119]. This is consistent
ith its dual roles in short patch BER pathway [6] and its role in
rocessing of DSBs during meiosis [120].ir 30 (2015) 53–67
4. Conclusions and some concluding remarks
Whereas the core mechanistic steps in different DNA repair
pathways are now reasonably well understood in principle, the
regulation of DNA repair processes remains elusive. Expression of
DNA repair genes is regulated at several levels, including post-
translational modiﬁcation [3,121,122]. Some aspects of cell cycle
regulation of DNA repair genes was  reviewed some years ago and
our analysis are in general agreement with this paper [123]. Regu-
lation of DNA repair and chromatin remodeling genes at the cell
cycle level is the topic of the present paper. Reassuringly, the
genome-wide cell cycle transcriptome studies largely conﬁrm stud-
ies at the protein level, when information is available. As evident
from our results and those of others, one DNA glycosylase is S
phase regulated (e.g. UNG), another one (TDG) is G1-regulated,
and two (SMUG1 and MBD4) are not cell cycle regulated, indi-
cating non-redundant functions of these uracil-DNA glycosylases.
Uracil-DNA glycosylase SMUG1 may  serve as a general backup
in genomic uracil-removal, particularly outside of S phase when
UNG2 levels are lower. In addition it has an apparently unique role
in removal of 5-hydroxymethyluracil from DNA. DNA glycosylases
removing oxidized or alkylated bases either had insigniﬁcant cell
cycle transcriptional proﬁles or were inconsistent between studies
(NEIL3, which was detected as upregulated in late S phase, G2 and
G1). However, NEIL1 was  previously found to be upregulated and
present in replication foci in S phase, indicating a possible role in
pre-replicative repair [54].
We ﬁnd that most of the FA genes are up-regulated during S
phase, indicating that interstrand cross-links (ICLs) are detected
and mainly repaired in S phase. The FA pathway may  coordinate
the activity of HR, MMR  and NER proteins in ICL repair [124,125].
Several FA proteins are known to bind to DNA containing ICLs either
directly or via nonerythroid  spectrin (also called SPTAN1) [126].
This protein also associates with ICLs in telomeres in the S phase
and is required for their maintenance [127]. Some repair of ICLs also
takes place outside of the S phase and in non-proliferating cells. This
replication-independent repair pathway is thought to be initiated
by RNA polymerase stalling; repair is slow and independent of the
FA proteins, but may  use some NER proteins and MMR  proteins
[18,128]. Proteins thought to be involved in this FA-independent
ICL repair are mostly not cell cycle regulated.
DNA repair by HRR is most active during S/G2 phase when
sister chromatids are available. In accordance with this, we found
the highest expression of most HRR genes in the S phase. How-
ever, HMG20B (also called BRAF35) expression peaks in M/G1.
HMG20B is a DNA-binding protein that interacts directly with
BRCA2, which is required for HRR. BRCA2, in interaction with
RAD51, is required for ﬁlament formation and strand invasion in
HRR of double strand breaks [129]. Interestingly, the cell cycle
pattern of HMG20B expression ﬁts well with the observation that
HMG20B and BRCA2 co-localized on mitotic chromosomes and that
injection of antibodies to HMG20B caused G2-delay in the cell cycle
[130]. These, and several observations not discussed here, indicate
that HMG20B is a multi-functional protein involved in DSB repair
and cell cycle regulation at the G2/M transition.
We ﬁnd that several genes that are critical for HRR (e.g. RAD51,
RAD54L, BRCA1 and BLM) are expressed during G1/S transition and
S phase, but are probably mostly used later in S phase when sister
chromatids increasingly are available and HRR is at its maximum
[131]. Repair by NHEJ is initiated by XRCC5 and XRCC6 which are
not cell cycle regulated, consistent with NHEJ being active through-
out the whole cell cycle. In the MRN  complex, only MRE11 is cell
cycle regulated, having induced expression during late S and G2
phase. Some reports show that the MRN  complex is activated by
protein phosphorylation which could explain why  these genes are
expressed independently of the cell cycle [132–134].
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Chromatin remodeling proteins have important roles in genome
aintenance processes, including DNA repair and DNA replication
reviewed in [135]) and at least for some types of repair recruit-
ent of chromatin regulators is cell cycle regulated [136]. Most
ikely, many mechanisms of DNA repair, DNA replication and chro-
atin remodeling must be integrated and co-regulated. We  ﬁnd
hat transcripts from 8 chromatin remodeling genes are most highly
xpressed in S or G1/S in at least two data sets. In addition, 8
hromatin remodeling genes are translationally upregulated in S or
1/S. Many of these are known, or suspected, to have roles in DSBR
y HRR or in restoration of nucleosome structure after HRR. Sev-
ral of these apparently have roles in restoration of the nucleosome
tructure after MMR  and NER. A requirement for chromatin remod-
ling has also been documented in BER, and appears to depend
n the type of nucleosomes present in proximity of the repair
atch and steps in the repair process [137,138]. In sum, DNA repair
ave cell cycle regulated expression more frequently than average
enes, particularly in S phase. Chromatin remodeling genes, how-
ver, were not cell cycle regulated at a signiﬁcantly higher level
han expected.
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